MESSAGE FROM THE CHAIRMAN

"Our strategy is to strive for excellence in the following key areas of our business:

Exceed expectations of our partners in commercialisation services [see PharmaLink].

By maximising returns of promoted products through sales force excellence.

Maintaining highest ethical standards.

Constantly improving Cost Effectiveness of operations

Bringing innovative and specialised medicine to Asia Pacific [see Inovail].

We aim to create leading market positions in the areas of Dermatology and Female Health by external and organic growth.

Innovation is created by leveraging our understanding of the marketplace to license in or develop innovative formulations in our areas of focus."

Inovail Holdings Pte Ltd is a newly-formed specialty pharmaceutical company focusing on market-driven innovation in the Asia Pacific Region.

Our areas of specialty are in primary care, dermatology and female healthcare. Within these areas, Inovail’s experienced teams are able to integrate capabilities ranging from market feasibility studies, regulatory affairs, marketing management, medical affairs. Our growth strategy is focused on driving innovation in the Asia Pacific Region.

Our activities range from in-licensing of innovative compounds to acquisition of existing brands. Inovail sees itself as a partner for the R&D based pharmaceutical industry that supports the refocusing of companies on their core businesses by assuming full responsibilities for various business areas, either by acquisition or in-licensing. Companies with investments in dermatology, complementary oncology and female healthcare will find value in our strategic partnership.

With the breadth of our services and the depth of our regional knowledge, we are the ideal strategic partner to bring your products to prominence in Asia Pacific.